II using response adapted Involved Site Radiotherapy in combination with Obinutuzumab (Gazyvaro) - GAZAI Trial (GAZyvaro and…

Overview of attention for article published in Trials, August 2019

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 13,120 followers.

RT @radoncpapers: Therapy of nodal Follicular Lymphoma (WHO grade 1/2) in clinical stage I/II using response adapted Involved Site Radiothe…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.